Stem cells are characterized by their ability for unlimited or prolonged self-renewal differentiation into highly distinct cell lineages. Because these properties are considered a very attractive source of cells for a wide range of clinical and pharmacological applications. Stem cells functions are subject to tightly regulated control mechanisms and still a lot more basic research have to be carried out to elucidate some of these aspects. Therefore, there are several challenges in stem cell research. As both adult and embryonic stem cells may provide a way for the development of innovative methods of drug discovery and screening, stem cells are also powerful tools in fundamental research and can provide a better understanding of the basic biology of human body and diseases. 

Inbiotec  has opened huge possibilities for cell therapy and regenerative medicine. With professional scientists and years of experience. Inbiotec provides high-quality products and services in the field of stem cell therapy development for customers all over the world. 

 During the last few years, remarkable progress has been made in gene and cell therapy. Positive proof-of- principle results have been obtained for several diseases, such as adrenoleukodystrophy, hemophilia IX, β-thalassemia, malignant glioblastoma, leukemia and other types of cancer.  

 Thus, it is expected that several new gene therapy products will enter the clinical arena in the not-so-distant future. With the ability to become many different types of cells, stem cells play a key role in the body's healing process and the regenerative medicine. 

Since march 2023, Inbiotec has been part of the AgroTurix Group.